Clariant’s shareholders approve all agenda items
April 04 2023 - 7:00AM
Clariant’s shareholders approve all agenda items
- Integrated Report, Financial
Statements and Consolidated
Financial Statements of
Clariant for the fiscal year 2022
approved
- Increased distribution of
CHF 0.42 per share
confirmed
- Proposed amendments to the Articles of Association
approved
- Günter von Au, Chairman of the Board of Directors,
confirmed in office
- All members of the Board of Directors
discharged and reelected
MUTTENZ, APRIL 4, 2023
Clariant, a focused, sustainable, and innovative specialty
chemical company, today held its 28th Annual General Meeting (AGM)
where shareholders approved all agenda items and resolutions as
proposed by the Board of Directors. The meeting in Basel,
Switzerland, was attended by 237 shareholders and shareholder
representatives accounting for 228'758'357 shares or around
68.92 % of the share capital of Clariant.
The Integrated Report 2022 as well as the Financial Statements
and Consolidated Financial Statements of Clariant for the 2022
fiscal year were approved with 94.65 % of the votes. The 2022
Compensation Report was also approved on an advisory basis with
89.09 % of the votes. The members of the Board of Directors
and the Executive Steering Committee/Executive Committee were
discharged with 90.86 % of the votes.
The Annual General Meeting reelected Günter von Au as Chairman
of the Board of Directors until the Annual General Meeting 2024
with 89.51 %. The ten other members of the Board of Directors
were also reelected by a large majority until the next Annual
General Meeting. The four members of the Compensation Committee
were confirmed in office for another year.
Following the proposal by the Board of Directors, the
shareholders agreed to a distribution of CHF 0.42 per share
with 94.74 %. This increased distribution shall be made
through capital reduction by way of par value reduction.
“We can be proud of the transformation that Clariant went
through over the past years to evolve into a true specialty
chemicals company,” said Günter von Au, Chairman of Clariant’s
Board of Directors. “Thanks to the trust and continuous support
from all our stakeholders including our shareholders, Clariant was
able to demonstrate that we set the right strategy for sustainable
value creation and profitable growth. Now it is about implementing
our concept and convincing the capital market.”
Conrad Keijzer, Chief Executive Officer of Clariant added: “In
2022, we successfully progressed towards our 2025 financial and
non-financial targets, despite a turbulent environment. Our
colleagues worked hard to deliver our own sustainability
transformation and that of our customers. Our future value creation
will be driven by our purpose-led growth strategy, by our strong
value-based culture and by our new operating model, that allows us
to be closer to our customers, act faster and empower our
people.”
All proposed amendments to the Articles of Association were
approved by the shareholders. The amendments were required as a
consequence of the revision of the Swiss Code of Obligations
regarding corporate law or recommended by Clariant to simplify
certain provisions or to adapt its Articles to newer standards.
Further, Dr. Balthasar Settelen, attorney, was reelected as
independent proxy until the next Annual General Meeting and KPMG
was confirmed as the statutory auditor for 2023.
The proposal for total compensation of the Board of Directors
for the term from the 2023 to the 2024 Annual General Meeting was
approved with 92.03 % of the votes, as was the total
compensation of the Executive Steering Committee for the 2024
fiscal year, with 89.41 % of the votes.
Please find additional documents related to the AGM available
for download on https://www.clariant.com/agm
CORPORATE
MEDIA RELATIONS Jochen DubielPhone
+41 61 469 63
63jochen.dubiel@clariant.com Anne
MaierPhone +41 61 469 63
63anne.maier@clariant.com Ellese CaruanaPhone
+41 61 469 63 63ellese.caruana@clariant.com |
INVESTOR
RELATIONS Andreas Schwarzwälder
Phone +41 61 469 63
73andreas.schwarzwaelder@clariant.com Maria
IvekPhone +41 61 469 63
73maria.ivek@clariant.com Thijs
BouwensPhone +41 61 469 63
73thijs.bouwens@clariant.com |
Follow us on Twitter, Facebook, LinkedIn, Instagram. This
media release contains certain statements that are neither reported
financial results nor other historical information. This document
also includes forward-looking statements. Because these
forward-looking statements are subject to risks and uncertainties,
actual future results may differ materially from those expressed in
or implied by the statements. Many of these risks and uncertainties
relate to factors that are beyond Clariant’s ability to control or
estimate precisely, such as future market conditions, currency
fluctuations, the behavior of other market participants, the
actions of governmental regulators and other risk factors such as:
the timing and strength of new product offerings; pricing
strategies of competitors; the Company’s ability to continue to
receive adequate products from its vendors on acceptable terms, or
at all, and to continue to obtain sufficient financing to meet its
liquidity needs; and changes in the political, social and
regulatory framework in which the Company operates or in economic
or technological trends or conditions, including currency
fluctuations, inflation and consumer confidence, on a global,
regional or national basis. Readers are cautioned not to place
undue reliance on these forward-looking statements, which speak
only as of the date of this document. Clariant does not undertake
any obligation to publicly release any revisions to these
forward-looking statements to reflect events or circumstances after
the date of these
materials. www.clariant.com Clariant is a focused,
sustainable, and innovative specialty chemical company based in
Muttenz, near Basel/Switzerland.
On 31 December 2022, Clariant totaled a staff number
of 11 148 and recorded sales of CHF 5.198 billion in
the fiscal year for its continuing businesses. As of
January 2023, the Group conducts its business through the
three newly formed Business Units Care Chemicals, Catalysts, and
Adsorbents & Additives and will report accordingly.
Clariant’s corporate strategy is led by the overarching purpose of
‘Greater chemistry – between people and planet,’ and reflects the
importance of connecting customer focus, innovation,
sustainability, and people. |
- Clariant Media Release 28th Annual General Meeting DE
20230404
- Clariant Media Release 28th Annual General Meeting EN
20230404
Clariant (LSE:0QJS)
Historical Stock Chart
From Feb 2025 to Mar 2025
Clariant (LSE:0QJS)
Historical Stock Chart
From Mar 2024 to Mar 2025